N-Acetyl Semax Amidate
Doubly modified ACTH(4-7) analogue heptapeptide with potent nootropic, neuroprotective, and neurotrophic properties acting through BDNF/NGF upregulation and transcriptome-level modulation of inflammatory and neurotransmitter gene networks
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
200 – 600 mcg/day
Compound profile
Scientific & efficacy data
Cognitive
Peptide profile
Moderate human trials
N-Acetyl Semax Amidate
200-300 mcg/day · Once daily
Molecular formula
C39H54N10O10S
- Mol. weight
- 855.0 g/mol
- CAS number
- Not assigned (N-Acetyl Semax Amidate); 80714-61-0 (parent Semax)
- PubChem
- 172638603 (N-Acetyl Semax Amidate); 9811102 (parent Semax)
- Developed · 1980s (Semax); N-Acetyl Semax Amidate developed subsequently as an enhanced research variant
- Academic research consortium
Multiple research institutions
Amino acid sequence
Sequence not publicly available or proprietaryBrain Protection
This peptide shields brain cells from damage by turning down harmful inflammation and boosting natural repair signals.
Memory & Learning
It increases BDNF, a protein that helps your brain form new connections and remember things better.
Focus & Attention
Users report sharper concentration during demanding mental tasks, likely from enhanced brain signaling.
Dosing
How much do I take?
200 – 600 mcg/day · divided 2-3 times daily
200 – 600 mcg/day
Divided 2-3 times daily
Covers all 2 documented dose levels · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for cognitive enhancement through bdnf and ngf-mediated neuroplasticity & neuroprotection during and after cerebral ischemic events or brain injury
Best for
Cognitive enhancement through BDNF and NGF-mediated neuroplasticity
N-Acetyl Semax Amidate is particularly well-suited for individuals focused on cognitive enhancement through bdnf and ngf-mediated neuroplasticity. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Neuroprotection during and after cerebral ischemic events or brain injury
N-Acetyl Semax Amidate is particularly well-suited for individuals focused on neuroprotection during and after cerebral ischemic events or brain injury. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Nootropic stacking for enhanced learning, memory, and cognitive processing speed
N-Acetyl Semax Amidate is particularly well-suited for individuals focused on nootropic stacking for enhanced learning, memory, and cognitive processing speed. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Attention and focus improvement for cognitively demanding tasks
N-Acetyl Semax Amidate is particularly well-suited for individuals focused on attention and focus improvement for cognitively demanding tasks. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare N-Acetyl Semax Amidate with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Intranasal spray · Subcutaneous injection
Route
Subcutaneous injection (into the fatty tissue just under the skin)—allows for consistent absorption and can be self-administered at home after proper training
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
5 common side effects · 2 serious
N-Acetyl Semax Amidate shows excellent safety tolerability in Russian clinical studies with no serious adverse events reported at therapeutic doses.
The amidate modification significantly enhances CNS penetration and metabolic stability compared to parent Semax, reducing dosing frequency.
Side effects are primarily mild nasal irritation, transient headaches during initiation, and rare increases in dopaminergic tone manifesting as restlessness or insomnia at high doses, easily managed through dose adjustment.
Russian clinical trials over 25+ years combined with molecular biology studies demonstrate N-Acetyl Semax Amidate's mechanism through dopamine receptor upregulation (measured via autoradiography), BDNF expression increases in cortex and hippocampus (30-50% elevation), and enhanced neuroprotection against ischemic injury in animal models.
Published data in psychopharmacology journals support cognitive benefits in elderly and post-stroke populations.
Common side effects · experienced by some users
Nasal irritation
Mild burning, dryness, or tingling in the nasal passages with intranasal spray administration. This is the most frequently reported side effect across all Semax formulations and is generally transient.
Management: Pre-moisturize nasal passages with saline spray. Alternate nostrils between doses. If persistent irritation occurs, consider subcutaneous injection as an alternative route.
Headache
Mild to moderate headache during the initial 1-3 days, likely related to rapid changes in BDNF levels and neurotrophic signaling in the brain as receptor adaptation occurs.
Management: Usually self-resolving within 2-3 days. Ensure adequate hydration. Reduce dose temporarily if headache persists. Standard OTC analgesics are appropriate if needed.
Mental overstimulation or restlessness
Increased mental alertness and energy that may manifest as restlessness, particularly with afternoon dosing or at higher doses. This reflects the stimulatory nature of Semax's dopaminergic and nootropic mechanisms.
Management: Confine dosing to morning hours (before noon). Reduce dose if overstimulation is uncomfortable. Avoid combining with other stimulants like high-dose caffeine.
Sleep difficulty
Difficulty falling asleep if the peptide is administered too late in the day, due to sustained neurostimulatory and neurotrophic signaling in the brain.
Management: Strictly limit dosing to morning and early afternoon (last dose before 2-3 PM). If insomnia persists, reduce to once-daily morning dosing only.
Appetite changes
Mild changes in appetite, either increased or decreased, during the initial days of use. May be related to melanocortin receptor activity or dopaminergic effects.
Management: Maintain regular eating patterns. Effect is typically transient and normalizes within the first week.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with N-Acetyl Semax Amidate
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
N-Acetyl Semax Amidate should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:N-Acetyl Selank (complementary mechanisms — Semax for cognitive stimulation via BDNF/dopamine and Selank for anxiolysis via GABA; this combination is used clinically in Russia) — May be used together under medical guidance.
- Safe:Alpha-GPC or Citicoline (provides choline substrate to support the enhanced cholinergic signaling driven by BDNF upregulation) — May be used together under medical guidance.
- Safe:Lion's Mane mushroom (complementary NGF-stimulating effects that may synergize with Semax's neurotrophic signaling) — May be used together under medical guidance.
With medications
- Caution:Other strong dopaminergic stimulants — risk of overstimulation and anxiety — Use with caution—discuss with your healthcare provider.
- Caution:MAO inhibitors — potential interaction with monoamine metabolism — Use with caution—discuss with your healthcare provider.
- Caution:High-dose caffeine — additive stimulatory effects may cause restlessness and insomnia — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside N-Acetyl Semax Amidate. Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Moderate human trials · first signs days 1-3
Evidence level
Moderate human trials
(Phase 1-2)
Regulatory status
Research compound
Onset of effects
Rapid
(hours to days)
How it works
N-Acetyl-Semax-Amidate is an enhanced version of the Russian nootropic Semax designed for improved memory and focus.
It works by activating brain-derived neurotrophic factor (BDNF), the protein responsible for nerve cell growth and survival. It also improves blood flow to the brain and protects against age-related cognitive decline.
The chemical modifications make it more stable and longer-lasting than regular Semax.
The deeper mechanism
N-Acetyl-Semax-Amidate (Ac-Met-Glu-His-Phe-Pro-Gly-Pro-amide) combines three chemical modifications to enhance bioavailability and duration compared to unmodified Semax: N-terminal acetylation prevents exopeptidase degradation, C-terminal amidation increases proteolytic resistance and receptor binding affinity, and the modified sequence maintains the critical MEHFP core motif responsible for BDNF activation.
The peptide activates transcription factor CREB (cAMP Response Element Binding) and ERK1/2 signaling pathways through BDNF receptor (TrkB) activation, leading to upregulation of BDNF mRNA and protein synthesis in hippocampus and prefrontal cortex.
Enhanced BDNF signaling promotes neuronal survival, dendritic branching, spine density, and synaptic plasticity critical for long-term memory formation.
N-Acetyl-Semax-Amidate also enhances cerebral blood flow through endothelial NO synthase (eNOS) activation and nitric oxide production, improving cerebral glucose and oxygen delivery. The peptide crosses the blood-brain barrier via peptide transporter-mediated transport.
Additionally, it enhances dopamine and serotonin availability through monoamine oxidase modulation while reducing glutamate excitotoxicity through NMDA receptor modulation.
What to expect
Days 1-3
What you might notice
- Increased mental clarity and alertness within hours of first dose
- Subtle improvement in focus and attention to detail
- Possible mild headache or nasal irritation as common initial effects
- BDNF levels are already rising — studies show measurable increase within 3 hours of administration
What's normal
- Stimulatory effects may be noticeable from the first dose — Semax has rapid onset
- Initial side effects like headache or restlessness are common and transient
- Cognitive effects are real but may be subtle in the first few days as neurotrophic signaling builds
What's next
- Continue consistent daily dosing — neurotrophic factor levels are building
- BDNF-mediated neuroplasticity requires sustained signaling over days to weeks for maximal effect
- Adjust timing if sleep is affected — move dosing earlier in the day
Week 1-2
What you might notice
- Clear improvement in cognitive processing speed and working memory
- Enhanced verbal fluency and ease of information retrieval
- Improved motivation and mental energy throughout the day
- Better stress resilience during cognitively demanding tasks
- Heightened sensory awareness and mental acuity
What's normal
- Cognitive enhancement effects should be clearly established by end of week one
- BDNF and NGF upregulation is driving active neuroplastic changes in the hippocampus and cortex
- Initial side effects should have resolved; if they persist, dose adjustment may be needed
What's next
- If using a 10-day course protocol, prepare for the scheduled break
- Cognitive benefits often continue to build even during the first few days off the peptide
- Consider adding complementary compounds (N-Acetyl Selank for anxiolysis, Alpha-GPC for choline support)
Week 2-4
What you might notice
- Peak cognitive enhancement — optimal BDNF/NGF-mediated neuroplasticity
- Sustained improvements in learning capacity and memory consolidation
- Enhanced creative thinking and problem-solving ability
- If on break between courses, benefits typically persist for days to weeks
- Some users note cumulative improvements across repeated treatment courses
What's normal
- Longer courses (20-30 days) approach peak effect during this period
- Benefits from BDNF-driven neuroplastic changes can persist beyond the active treatment period
- A scheduled break between courses helps maintain long-term effectiveness
What's next
- Follow prescribed cycling protocol — typically 10-day course with 20-day break, or 20-30 day course with 2-3 week break
- Assess overall cognitive improvements and adjust protocol for subsequent courses
- Neuroplastic changes established during the treatment course provide a foundation for sustained cognitive benefit
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to N-Acetyl Semax Amidate over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked
What is the difference between Semax, N-Acetyl Semax, and N-Acetyl Semax Amidate?
Semax is the parent heptapeptide (Met-Glu-His-Phe-Pro-Gly-Pro) derived from ACTH(4-7) with a Pro-Gly-Pro extension. N-Acetyl Semax adds an acetyl group to the N-terminus, protecting against aminopeptidase degradation. N-Acetyl Semax Amidate adds both N-terminal acetylation AND C-terminal amidation, providing protection from both aminopeptidases and carboxypeptidases. This dual modification gives N-Acetyl Semax Amidate the longest half-life, greatest metabolic stability, and best blood-brain barrier penetration of the three forms, making it the most potent per milligram.
How does N-Acetyl Semax Amidate compare to N-Acetyl Selank?
These two peptides target complementary neurochemical systems and are frequently used together. N-Acetyl Semax Amidate is primarily stimulatory and nootropic — it upregulates BDNF, NGF, and dopaminergic signaling to enhance cognition, focus, and mental energy. N-Acetyl Selank is primarily anxiolytic and calming — it modulates GABAergic signaling and enkephalin metabolism to reduce anxiety and improve stress resilience. Together, they provide balanced cognitive enhancement (from Semax) with emotional stability (from Selank). In Russia, Selank and Semax are sometimes prescribed concurrently.
Is Semax actually approved as a medication somewhere?
Yes. Parent Semax is approved as a medication in Russia and has been used clinically since the 1990s, primarily for the treatment of ischemic stroke and cognitive disorders. The standard clinical protocol uses 6000 mcg/day (6 mg/day) intranasally for 10-day courses. Clinical studies in stroke patients have demonstrated that Semax increases plasma BDNF levels, improves functional recovery (Barthel index), and enhances motor performance. However, neither Semax nor N-Acetyl Semax Amidate has received FDA approval or regulatory authorization outside of Russia.
Can N-Acetyl Semax Amidate really darken hair?
Some users report gradual hair darkening with prolonged Semax use. This is attributed to the peptide's structural relationship to ACTH and its activity at melanocortin receptors, particularly MC1R, which regulates melanin production. ACTH fragments are known to stimulate melanogenesis. The effect is typically subtle, reversible upon discontinuation, and not experienced by all users. Some individuals actually consider this a positive cosmetic side effect.
What is the evidence for cognitive benefits in healthy people (not stroke patients)?
Most rigorous clinical evidence for Semax comes from stroke patients, where it has demonstrated BDNF elevation and functional recovery improvements. For healthy cognitive enhancement, the evidence base consists of preclinical studies showing BDNF and NGF upregulation, enhanced neuroplasticity, and improved learning in animal models, along with Semax's long history of clinical use in Russia for cognitive disorders. The transcriptome-level data showing modulation of 394+ genes related to neurotransmission provides a strong mechanistic basis, but large-scale placebo-controlled trials in healthy individuals have not been published in English-language peer-reviewed journals.
Why is the dosing so much lower than the 6 mg/day used in Russian clinical trials?
The 6000 mcg/day (6 mg/day) dose used in Russian stroke trials was for unmodified parent Semax. N-Acetyl Semax Amidate has dramatically enhanced metabolic stability due to dual N-acetylation and C-amidation, meaning it resists enzymatic degradation from both ends of the peptide chain. This results in higher effective brain concentrations per milligram administered, a longer duration of action, and improved BBB penetration — so lower doses (typically 0.1-0.6 mg) are used in nootropic protocols to achieve comparable or superior CNS effects to higher doses of the parent compound.
Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for N-Acetyl Semax Amidate, on one page.